Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

"Norwalk-Like Viruses"

Public Health Consequences and Outbreak Management

Please note: An erratum has been published for this article. To view the erratum, please click here.

Summary

"Norwalk-like viruses" (NLVs) cause outbreaks of gastroenteritis and are spread frequently through contaminated food or water. Molecular diagnostics now enables detecting viruses in clinical and environmental specimens, linking of NLV strains causing outbreaks in multiple geographic locations, and tracing them to their sources in contaminated food or water. This report reviews recent advances in NLV detection and provides guidelines and recommendations for investigating NLV-related outbreaks, including specimen collection and disease prevention and control. This report also updates information provided in CDC's previously published, Viral Agents of Gastroenteritis: Public Health Importance and Outbreak Management (MMWR 1990;39 [No. RR-5]:1--24). These CDC recommendations are intended for public health professionals who investigate outbreaks of acute gastroenteritis but could be useful in academic and research settings as well.

INTRODUCTION

During the early 1970s, before the discovery of diarrhea-causing viruses, an etiologic agent could be detected only among a limited proportion of persons with gastroenteritis. Subsequently, with the discovery of Norwalk virus (1), rotavirus (2), astrovirus (3,4), and enteric adenovirus (5), researchers began to recognize viruses as causative agents of gastroenteritis. However, progress in detecting and managing outbreaks of disease caused by these agents was hampered by the unavailability of sensitive and specific diagnostic tests that could be applied outside research settings. Although outbreaks of nonbacterial gastroenteritis were recognized as a public health concern, electron microscopy (EM) proved to be a tedious and insensitive method for routine examination for enteric viruses in stool specimens collected during outbreak investigations.

Detection rates improved with the development of immunologic assays (6--11), and 19%--42% of nonbacterial outbreaks were attributed to Norwalk virus in targeted studies conducted during the late 1970s and 1980s (12,13). However, because reagents for these assays came from human volunteers, the reagents were available only in limited quantities and only at certain facilities. Consequently, outbreaks were not fully investigated, and a substantial number were still labeled as being of unknown etiology. Furthermore, because of the antigenic and genetic diversity of "Norwalk-like viruses"* (NLVs) and the inability to cultivate these viruses in cell lines, developing assays to detect the full spectrum of NLVs associated with outbreaks of gastroenteritis was not possible. To circumvent these obstacles to laboratory diagnosis, clinical and epidemiologic criteria were developed that correlate with the presence of NLVs in outbreaks of acute gastroenteritis (14). These criteria included a) stool specimens that are negative for bacterial and parasitic pathogens; b) percentage of cases with vomiting >50%; c) mean (or median) duration of illness of 12--60 hours; and d) if available, mean (or median) incubation period of 24--48 hours.

During the early 1990s, breakthroughs in cloning and sequencing of Norwalk virus and Southampton virus (15--18) led to the development of sensitive molecular assays (e.g., reverse transcription-polymerase chain reaction [RT-PCR]), nucleotide hybridization probes, and enzyme-linked immunosorbent assays (ELISA) that used baculovirus-expressed viral antigens (19--33). Using these assays, researchers demonstrated that NLVs caused a majority of foodborne gastroenteritis outbreaks in Minnesota and approximately 96% of 90 outbreaks of nonbacterial gastroenteritis reported to CDC during January 1996--June 1997 (34,35). These data demonstrate that NLVs are a common cause of outbreaks of nonbacterial gastroenteritis in the United States and similar findings have been reported in other countries (36--42).

In addition to improving detection rates of NLVs in outbreaks of gastroenteritis, advances in laboratory methods have also refined the epidemiologic investigation of these outbreaks. This progress is well-illustrated in reports of recent outbreaks linked to contaminated water, oysters, and other food items (43--49). In certain outbreaks, the detection of a genetically identical strain of NLV among patients from different geographic locations provided substantial evidence to support the link among the cases that was indicated by epidemiologic observations. In other outbreaks, the detection in the implicated vehicle of NLVs with a sequence identical to that of the strain detected from the patients confirmed the causal link.

Although diagnostic advances have improved the investigation of gastroenteritis outbreaks, they have also required that investigators collect clinical and environmental specimens accurately and in a timely manner and collaborate with the laboratory during the investigation. This report reviews recent advances in NLV diagnosis, and provides CDC's guidelines and recommendations for investigating gastroenteritis outbreaks, including methods for collecting specimens and preventing and controlling outbreaks.

BIOLOGY AND EPIDEMIOLOGY OF NLVs

Taxonomy

Norwalk virus is the prototype strain of genetically and antigenically diverse single-stranded RNA (ribonucleic acid) viruses, previously called small round-structured viruses (SRSVs), that are classified in the genus Norwalk-like viruses in the family Caliciviridae (50). Other genera in the Caliciviridae family include "Sapporo-like viruses," which also cause gastroenteritis among both children and adults, and Lagovirus and Vesivirus, neither of which are pathogenic for humans. NLVs can be divided into three distinct genogroups: GI, GII, and GIII (51). GI and GII NLVs infect humans and include 5 and 10 genetic clusters, respectively; GIII NLVs infect pigs and cows.

Endemic Disease

The burden of NLV-caused endemic disease is unknown because simple and sensitive diagnostic assays are not readily available. However, the potential burden of NLV disease can be understood by examining the disease burden of gastroenteritis of all causes with the insights obtained during the limited number of studies in which newer diagnostics for NLVs have been applied. Annually, approximately 267,000,000 episodes of diarrhea leading to 612,000 hospitalizations and 3,000 deaths occur among adults in the United States (52). An etiologic agent is identified in <10% of these cases, but studies to assess the disease burden of NLV among hospitalized adults are underway. In other countries (e.g., the Netherlands and England [53--55]), NLVs have been reported to account for 5%--17% of cases of diarrhea in the community and 5%--7% of cases requiring treatment by physicians.

Although rotavirus is the leading cause of severe diarrhea among children (56), data from recent studies demonstrate that NLVs also might be a factor in childhood gastroenteritis (57--65). For example, NLVs were detected in 20% of 783 stool specimens collected during acute gastroenteritis episodes among Finnish children prospectively followed from age 2 months to 2 years (65). "Sapporo-like viruses" were detected in an additional 9% of cases.

Clinical Features

NLV-caused gastroenteritis has an average incubation period of 12--48 hours and lasts 12--60 hours. Illness is characterized by acute onset of nausea, vomiting, abdominal cramps, and diarrhea. Vomiting is relatively more prevalent among children, whereas a greater proportion of adults experience diarrhea. Patients can experience vomiting alone, a condition first identified as winter vomiting disease (66). Constitutional symptoms (e.g., headache, fever, chills, and myalgia) are frequently reported. Although rare, severe dehydration caused by NLV gastroenteritis can be fatal, with this outcome occurring among susceptible persons (e.g., older persons with debilitating health conditions). No long-term sequelae of NLV infection have been reported.

Transmission Mode

Fecal-oral spread is probably the primary NLV transmission mode, although airborne and fomite transmission might facilitate spread during outbreaks (67--71). Frequently during an outbreak, primary cases result from exposure to a fecally contaminated vehicle (e.g., food or water), whereas secondary and tertiary cases among contacts of primary cases result from person-to-person transmission (72). For 348 outbreaks of NLV gastroenteritis reported to CDC during January 1996--November 2000, food was implicated in 39%, person-to-person contact in 12%, and water in 3%; 18% could not be linked to a specific transmission mode (Figure 1).

Previously, researchers believed that a person remained contagious 48--72 hours after recovery from NLV gastroenteritis (73). However, data from recent studies using more sensitive diagnostic assays demonstrate that this belief might require further evaluation. During a 1994 study of 50 volunteers exposed to NLV, 82% became infected; of these infections, 68% resulted in illness, whereas the remaining 32% were asymptomatic (74). Viral shedding in stool began 15 hours after virus administration and peaked 25--72 hours after virus administration. Unexpectedly, viral antigen could be detected by ELISA in stool specimens collected 7 days after inoculation in both symptomatic and asymptomatic persons. In a later study of infected volunteers, viral antigen in stool was detected <2 weeks after administration of virus (75). Anecdotal evidence from outbreak investigations also demonstrates that viral shedding can occur for a prolonged period and in the absence of clinical illness (46,48,76--80). However, the epidemiologic significance of these findings is unclear. Additional research is need to determine whether the viral antigen that is detectable for prolonged periods after recovery from illness is evidence of infectious virus or just a soluble antigen and to assess the time of maximal viral shedding so that control measures can focus on the period during which the person is most likely to be contagious.

Characteristics of NLVs facilitate their spread during epidemics (Table 1). The low infectious dose of NLVs (i.e., <100 viral particles [81]) readily allows spread by droplets, fomites, person-to-person transmission, and environmental contamination, as evidenced by the increased rate of secondary and tertiary spread among contacts and family members. Prolonged duration of viral shedding that can occur among asymptomatic persons increases the risk for secondary spread and is of concern in foodhandler-related transmission. The ability of the virus to survive relatively high levels of chlorine (82) and varying temperatures (i.e., from freezing to 60 C) (81) facilitates spread through recreational and drinking water and food items, including steamed oysters (83). Because of the diversity of NLV strains, lack of complete cross-protection, and lack of long-term immunity, repeated infections can occur throughout life.

Immunity

Studies of NLV immunity have been hampered by the inability of these viruses to be cultivated in cell lines, and thus, in vitro neutralization assays are not available. Early studies indicated that approximately 50% of persons exposed to NLVs experience illness and acquire short-term homologous immunity (i.e., against the same strain) that is correlated with serum antibody levels (84). Certain studies also demonstrated, paradoxically, that persons with higher levels of preexisting NLV antibodies would probably experience illness if exposed to the virus (84,85).

A recent study using molecular assays confirmed that approximately 50% of volunteers exposed to NLVs are susceptible to illness, but the study demonstrated also that approximately 80% become infected, with certain infections being asymptomatic (74). Although a trend for higher rates of viral shedding, seroconversion, and clinical illness was observed among those with higher levels of preexisting antibody, 60% of volunteers without preexisting antibody also demonstrated a seroconversion. Researchers hypothesized that certain persons might be genetically more susceptible to NLV infection and disease. If true, this hypothesis could explain why those with greater levels of preexisting antibody are more likely to experience NLV infection and disease after reexposure to virus.

Outbreaks

Outbreaks of NLV gastroenteritis occur in multiple settings. Of 348 such outbreaks reported to CDC during January 1996--November 2000, a total of 39% occurred in restaurants; 29% occurred in nursing homes and hospitals; 12% in schools and day care centers; 10% in vacation settings, including cruise ships; and 9% in other settings (Figure 2).

Nursing Homes and Residential Institutions

Protracted outbreaks of NLV disease have been reported among elderly persons living in institutional settings, (e.g., nursing homes) (86,87). In certain cases, the outbreak was initially caused by a common-source exposure to a fecally contaminated vehicle (e.g., food or water). Later, the outbreak spreads through person-to-person transmission among the residents; this spread is facilitated by the enclosed living quarters and reduced levels of personal hygiene that result from incontinence, immobility, or reduced mental alertness. Because of underlying medical conditions, the disease among these persons can be severe or fatal.

Restaurants and Catered Events

A report from Minnesota demonstrates the relevance of NLVs as a cause of foodborne outbreaks (34). The survey determined that 41% of 295 foodborne outbreaks reported in Minnesota during 1981--1998 met the epidemiologic criteria for NLV gastroenteritis. Further, NLVs were detected in 70% of 23 foodborne outbreaks investigated during 1996--1998 in which molecular diagnostics were used to test stool specimens. Investigations of foodborne NLV outbreaks have implicated multiple food items, including oysters, salads, sandwiches, cakes, frosting, raspberries, drinking water, and ice (43--49,88--91). In certain outbreaks, the implicated food is fecally contaminated with NLVs at its source (e.g., oysters harvested from fecally contaminated waters or raspberries irrigated with sewage-contaminated water). However, foodhandlers might contaminate food items during preparation. The risk for contamination through foodhandlers is increased when the food item is consumed without further cooking (e.g., ready-to-eat foods) and when a semiliquid food (e.g., cake frosting or salad dressing) is contaminated so that a small inoculum is mixed and spread to multiple persons.

Cruise Ships

Passengers and crew members on cruise ships and naval vessels are frequently affected by outbreaks of NLV gastroenteritis (35,92,93). These ships dock in countries where levels of sanitation might be inadequate, thus increasing the risk for contamination of water and food taken aboard or for having a passenger board with an active infection. After a passenger or crew member brings the virus on board, the close living quarters on ships amplify opportunities for person-to-person transmission. Furthermore, the arrival of new and susceptible passengers every 1 or 2 weeks on affected cruise ships provides an opportunity for sustained transmission during successive cruises. NLV outbreaks extending beyond 12 successive cruises have been reported (94).

PREVENTION AND CONTROL OF NLV OUTBREAKS

Although person-to-person spread might extend NLV gastroenteritis outbreaks, the initiating event is often the contamination of a common vehicle (e.g., food or water). Consequently, efforts to prevent both the initial contamination of the implicated vehicle and subsequent person-to-person NLV transmission will prevent the occurrence and spread of NLV gastroenteritis outbreaks.

Foodborne Transmission

Theoretically, any food item can potentially be infected with NLVs through fecal contamination. However, certain foods are implicated more often than others in outbreaks of NLV gastroenteritis. Shellfish (e.g., oysters or clams) tend to concentrate in their tissues NLVs that contaminate the waters from which they are harvested (95,96), and even harvests meeting bacteriologic standards of hygiene can contain NLVs. In addition, cooking (e.g., steaming) might not completely inactivate NLVs (83). Until reliable indicators for routine monitoring of viral contamination of harvest waters and shellfish are available, measures to prevent the contamination of harvest waters with human waste (e.g., surveillance of the shoreline for potential sources of fecal contamination and restricting boaters from dumping waste overboard) are probably a useful means of preventing shellfish-associated NLV gastroenteritis outbreaks.

Food contamination by infectious foodhandlers is another frequent cause of NLV gastroenteritis outbreaks. Because of the low infectious dose of NLVs and the high concentration of virus in stool, even a limited contamination can result in substantial outbreaks. Ready-to-eat foods that require handling but no subsequent cooking (e.g., salads and deli sandwiches) pose greater risk. Previously, the exclusion of ill foodhandlers for 48--72 hours after resolution of illness was recommended to prevent outbreaks caused by foodhandlers (97). Data from recent human volunteer and epidemiologic studies demonstrate that viral antigen can be shed for a longer duration after recovery from illness and in the absence of clinical disease. Although data are limited regarding whether this detectable viral antigen represents infectious virus, foodhandlers should be required to maintain strict personal hygiene at all times.

Waterborne Transmission

Although waterborne outbreaks are far less common than foodborne outbreaks, NLV gastroenteritis outbreaks have been associated with sources of contaminated water, including municipal water, well water, stream water, commercial ice, lake water, and swimming pool water. Because current analytic methods do not permit direct monitoring of NLVs in water, indicator organisms (e.g., coliform bacteria) have been used as proxy indicators of fecal contamination. However, because the size, physiology, and susceptibility to physical treatment and disinfection of bacterial indicators differ from those of NLVs, inherent limitations of this approach exist. Until reliable methods for assessing the occurrence and susceptibility to treatment of NLVs are available, prevention methods should focus on reducing human waste contamination of water supplies. If drinking or recreational water is suspected as being an outbreak source, high-level chlorination (i.e., 10 ppm or 10 mg/L for >30 minutes) might be required for adequate disinfection; however, even this method might be insufficient in certain cases (82).

Person-to-Person Transmission

Person-to-person spread of NLVs occurs by direct fecal-oral and airborne transmission. Such transmission plays a role in propagating NLV disease outbreaks, notably in institutional settings (e.g., nursing homes and day care centers) and on cruise ships. Although interruption of person-to-person transmission can be difficult, certain measures might help. Frequent handwashing with soap and water is an effective means of prevention. The recommended procedure is to rub all surfaces of lathered hands together vigorously for >10 seconds and then thoroughly rinse the hands under a stream of water. Because spattering or aerosols of infectious material might be involved in disease transmission, wearing masks should be considered for persons who clean areas substantially contaminated by feces or vomitus (e.g., hospital or nursing home personnel). Soiled linens and clothes should be handled as little as possible and with minimum agitation. They should be laundered with detergent at the maximum available cycle length and then machine dried. Because environmental surfaces have been implicated in the transmission of enteric viruses, surfaces that have been soiled should be cleaned with an appropriate germicidal product (e.g., 10% solution of household bleach) according to the manufacturer's instructions. In situations in which the epidemic is extended by periodic renewal of the susceptible population (e.g., camps and cruise ships), the facility or institution might have to be closed until it can be cleaned appropriately.

DIAGNOSTIC METHODS

Advances in methods for detecting NLVs have changed our understanding of the epidemiology of these viruses. The following sections provide a summary of the commonly available diagnostic methods, which are extensively reviewed elsewhere (98).

Electron Microscopy and Immune Electron Microscopy

Under the electron microscope, NLVs can be identified by their characteristic morphology. Approximately 106--107/ml of virus in stool is required for visualization by EM; therefore, this technique is useful only for specimens collected during the early stages of illness when substantial quantities of virus are shed. Even among experimentally infected volunteers, the virus can be found in only 10%--20% of fecal specimens collected on days 2 or 3 of illness.

Immune electron microscopy (IEM) can improve the sensitivity of EM by 10- to 100-fold. In one type of IEM, convalescent-phase serum from patients is coated on the examination grid of the microscope before stool specimens are applied. The antibody on the grid traps homologous virus, thereby increasing diagnostic yield. However, IEM has certain disadvantages, the greatest of which is that success is highly dependant on the skill and expertise of the microscopist. Furthermore, the virus might be totally masked if a large excess of antibody is present, resulting in a false-negative test.

Enzyme Immunoassays

The expression in baculoviruses of the capsid proteins of NLVs that self-assemble into stable virus-like particles has allowed the detection of these viruses by ELISAs. To develop assays to detect virus in fecal specimens, the expressed capsid antigens have been used to generate hyperimmune antibodies in laboratory animals. These assays have been reported to detect the presence of 104--106 viral particles/ml in clinical specimens. To date, these assays have been type-specific, but broadly reactive tests are under development.

The baculovirus-expressed viral antigen can be directly used for detection of antibodies to NLVs in patient's sera by enzyme immunoassay. Because certain adults have preexisting immunoglobulin G (IgG) antibodies to NLVs, a single serum specimen is insufficient to indicate recent infection. Seroconversion, defined as a >4-fold rise in IgG antibody titer during acute- and convalescent-phase sera, is indicative of a recent infection. In outbreak settings, if at least half of affected persons seroconvert to a specific NLV, that viral strain can be designated as etiologic. Titers can begin to rise by the fifth day after onset of symptoms, peak at approximately the third week, and begin to fall by the sixth week. Hence, for IgG assays, the acute-phase serum should be drawn within the first 5 days and the convalescent-phase serum during the third to sixth weeks. In certain cases where diagnosis is critical (e.g., when a foodhandler is implicated as the source of an outbreak), single assays of serum immunoglobulin A (IgA) antibody can be successful if specimens are collected 7--14 days after exposure. In addition to potential difficulties in obtaining an adequate number of serum specimens during outbreaks, serologic assays are currently limited by the fact that the available array of expressed NLV antigens is insufficient to detect all antigenic types of NLVs.

Nucleic Acid Hybridization Assays and RT-PCR

Nucleic acid hybridization assays and RT-PCR assays to detect NLV genome in clinical and environmental specimens have provided a sensitive and specific tool for NLV-outbreak investigations. High sensitivity of these assays (i.e., ability to detect 102--104 viral particles/ml in stool) is both an asset and a liability because extreme care is required to avoid contamination in the laboratory. In addition, although the available primers for RT-PCR assays detect multiple strains of NLVs, certain strains can escape detection. Efforts are ongoing to develop universal or degenerate primers that would detect the majority of NLV strains that cause gastroenteritis outbreaks.

Applying New Diagnostics in Outbreak Investigations

Application of new molecular diagnostics has expanded the scope of outbreak investigations, as demonstrated in recent outbreaks (Table 2), because outbreak source vehicles (e.g., food or water) can be definitively implicated by detecting NLVs in environmental specimens. However, these methods are not sufficiently developed to be routinely applied. Through nucleotide sequencing, establishing an irrefutable genetic link between outbreaks that occur through a single contaminated vehicle that is distributed in multiple geographic locations is possible.

RECOMMENDATIONS REGARDING SPECIMEN COLLECTION FOR DIAGNOSIS OF NLVs*

Clinical Specimens

Stool

Timing. Specimen collection for viral testing should begin on day 1 of the epidemiologic investigation. Any delays to await testing results for bacterial or parasitic agents could preclude establishing a viral diagnosis. Ideally, specimens should be obtained during the acute phase of illness (i.e., within 48--72 hours after onset) while the stools are still liquid or semisolid because the level of viral excretion is greatest then. With the development of sensitive molecular assays, the ability to detect viruses in specimens collected later in the illness has been improved. In specific cases, specimens might be collected later during the illness (i.e., 7--10 days after onset), if the testing is necessary for either determining the etiology of the outbreak or for epidemiologic purposes (e.g., a specimen obtained from an ill foodhandler who might be the source of infection). If specimens are collected late in the illness, the utility of viral diagnosis and interpretation of the results should be discussed with laboratory personnel before tests are conducted.

Number and Quantity. Ideally, specimens from >10 ill persons should be obtained during the acute phase of illness. Bulk samples (i.e., 10--50 ml of stool placed in a stool cup or urine container) are preferred, as are acute diarrhea specimens that are loose enough to assume the shape of their containers. Serial specimens from persons with acute, frequent, high-volume diarrhea are useful as reference material for the development of assays. The smaller the specimen and the more formed the stool, the lower the diagnostic yield. Rectal swabs are of limited or no value because they contain insufficient quantity of nucleic acid for amplification.

Storage and Transport. Because freezing can destroy the characteristic viral morphology that permits a diagnosis by EM, specimens should be kept refrigerated at 4 C. At this temperature, specimens can be stored without compromising diagnostic yield for 2--3 weeks, during which time testing for other pathogens can be completed. If the specimens have to be transported to a laboratory for testing, they should be bagged and sealed and kept on ice or frozen refrigerant packs in an insulated, waterproof container. If facilities for testing specimens within 2--3 weeks are not available, specimens can be frozen for antigen or PCR testing.

Vomitus

Vomiting is the predominant symptom among children, and specimens of vomitus can be collected to supplement the diagnostic yield from stool specimens during an investigation. Recommendations for collection, storage, and shipment of vomitus specimens are the same as those for stool specimens.

Serum

Timing. If feasible, acute- and convalescent-phase serum specimens should be obtained to test for a diagnostic >4-fold rise in IgG titer to NLVs. Acute-phase specimens should be obtained during the first 5 days of symptoms, and the convalescent-phase specimen should be collected from the third to sixth week after resolution of symptoms.

Number and Quantity. Ideally, 10 pairs of specimens from ill persons (i.e., the same persons submitting stool specimens) and 10 pairs from well persons (controls) should be obtained. Adults should provide 5--7 ml of blood, and children should provide 3--4 ml.

Storage. Specimens should be collected in tubes containing no anticoagulant, and the sera should be spun off and frozen. If a centrifuge is not available, a clot should be allowed to form, and the serum should be decanted and frozen. If this step cannot be accomplished, the whole blood should be refrigerated but not frozen.

Environmental Specimens

NLVs cannot be detected routinely in water, food, or environmental specimens. Nevertheless, during recent outbreaks (33--36), NLVs have been detected successfully in vehicles epidemiologically implicated as the source of infection. If a food or water item is strongly suspected as the source of an outbreak, then a sample should be obtained as early as possible and stored at 4 C. If the epidemiologic investigation confirms the link, a laboratory with the capacity to test these specimens should be contacted for further testing. If drinking water is suspected, special filtration (45) of large volumes (i.e., 5--100 liters) of water can concentrate virus to facilitate its detection.

CONSULTATION AND ASSISTANCE

During any outbreak, CDC's National Center for Infectious Diseases, Division of Viral and Rickettsial Diseases, Respiratory and Enteric Viruses Branch, Viral Gastroenteritis Section, (Telephone: [404] 639-3607) is available to provide assistance. If, after consultation, viral diagnostic services would be useful, specimens may be shipped to CDC's Viral Gastroenteritis Section with the following provisions:

  • A unique identifier for each patient (preferably not the patient's name) should be included on each specimen.
  • Stool specimens should be shipped as soon as they can be batched. Individual containers should be verified as being leak proof and then enclosed in a plastic bag. The entire collection should be bagged in plastic and placed in a padded, insulated box with refrigerant packs.
  • Frozen acute- and convalescent-phase serum samples should be batched and sent in a single shipment. Waterproof, padded, insulated boxes should be used, with dry ice added to maintain freezing. Whole-blood samples should not be frozen, and refrigerant packs should be used instead of dry ice.
  • Final notification should be made by telephone to (404) 639-3607 immediately before shipping.
  • All shipments should be sent by overnight mail, to arrive on a weekday, addressed to
NCID/DVRD/REVB/VGS
Attention: Dash Unit 75
Centers for Disease Control and Prevention
1600 Clifton Road, N.E.
Atlanta, GA 30333

Reporting of Outbreaks to CDC

All suspected foodborne outbreaks of viral gastroenteritis for which specimens are sent to CDC for laboratory testing should be reported to CDC on a standard form. This form and instructions for completing it are available on the Internet at <http://www.cdc.gov/ncidod/dbmd/outbreak/report_f.htm> (accessed May 1, 2001).

References

  1. Kapikian AZ, Wyatt RG, Dolin R, et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972;10:1075--81.
  2. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973;2:1281--3.
  3. Appleton H, Higgins PG. Viruses and gastroenteritis in infants [Letter]. Lancet 1975;1:1297.
  4. Madeley CR, Cosgrove BP. Viruses in infantile gastroenteritis [Letter]. Lancet 1975;2:124.
  5. Madeley CR, Cosgrove BP, Bell EJ, Fallon RJ. Stool viruses in babies in Glasgow. I. Hospital admissions with diarrhoea. J Hyg 1977;78:261--73.
  6. Greenberg HB, Wyatt RG, Valdesuso J, et al. Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol 1978;2:97--108.
  7. Greenberg HB, Kapikian AZ. Detection of Norwalk agent antibody and antigen by solid-phase radioimmunoassay and immune adherence hemagglutination assay. J Am Vet Med Assoc 1978;173:620--3.
  8. Dolin R, Roessner KD, Treanor JJ, Reichman RC, Phillips M, Madore HP. Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis. J Med Virol 1986;19:11--8.
  9. Blacklow NR, Cukor G, Bedigian MK, et al. Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol 1979;10:903--9.
  10. Herrmann JE, Nowak NA, Blacklow NR. Detection of Norwalk virus in stools by enzyme immunoassay. J Med Virol 1985;17:127--33.
  11. Treanor JJ, Madore HP, Dolin R. Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis. J Virol Methods 1988;22:207--14.
  12. Kaplan JE, Gary GW, Baron RC, et al. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med 1982;96:756--61.
  13. Greenberg HB, Valdesuso J, Yolken RH, et al. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis 1979;139:564--8.
  14. Kaplan JE, Feldman R, Campbell DS, Lookabaugh C, Gary GW. Frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Pub Health 1982;72:1329--32.
  15. Xi JN, Graham DY, Wang KN, Estes MK. Norwalk virus genome cloning and characterization. Science 1990;250:1580--3.
  16. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology 1993;195:51--61.
  17. Matsui SM, Kim JP, Greenberg HB, et al. Isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest 1991;87:1456--61.
  18. Lambden PR, Caul EO, Ashley CR, Clarke IN. Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science 1993;259:516--9.
  19. Jiang X, Wang J, Graham DY, Estes MK. Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol 1992;30:2529--34.
  20. Moe CL, Gentsch J, Ando T, et al. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol 1994;32:642--8.
  21. Ando T, Monroe SS, Noel JS, Glass RI. One-tube method of reverse-transcription polymerase chain reaction to efficiently amplify a 3-kilobase region from the RNA polymerase gene to the poly(A) tail of small round-structured viruses (Norwalk-like viruses). J Clin Microbiol 1997;35:570--7.
  22. Ando T, Mulders MN, Lewis DC, Estes MK, Monroe SS, Glass RI. Comparison of the polymerase region of small round structured virus strains previously classified in three antigenic types by solid-phase immune electron microscopy. Arch Virol 1994;135:217--26.
  23. Green J, Gallimore CI, Norcott JP, Lewis D, Brown DW. Broadly reactive reverse transcriptase polymerase chain reaction for the diagnosis of SRSV-associated gastroenteritis. J Med Virol 1995;47:392--8.
  24. Ando T, Monroe SS, Gentsch JR, Jin Q, Lewis DC, Glass RI. Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J Clin Microbiol 1995;33:64--71.
  25. Jiang X, Cubitt D, Hu J, et al. Development of an ELISA to detect MX virus, a human calicivirus in the Snow Mountain agent genogroup. J Gen Virol 1995;76:2739--47.
  26. Jiang X, Wang J, Estes MK. Characterization of SRSVs using RT-PCR and a new antigen ELISA. Arch Virol 1995;140:363--74.
  27. Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK. Expression, self-assembly, and antigenicity of a Snow Mountain agent-like calicivirus capsid protein. J Clin Microbiol 1995;33:1452--5.
  28. Jiang X, Matson DO, Cubitt WD, Estes MK. Genetic and antigenic diversity of human caliciviruses (HuCVs) using RT-PCR and new EIAs. Arch Virol Suppl 1996;12:251--62.
  29. Dingle KE, Lambden PR, Caul EO, Clarke IN. Human enteric Caliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus. J Gen Virol 1995;76:2349--55.
  30. Herrmann JE, Blacklow NR, Matsui SM, et al. Monoclonal antibodies for detection of Norwalk virus antigen in stools. J Clin Microbiol 1995;33:2511--3.
  31. Green KY, Kapikian AZ, Valdesuso J, Sosnovtsev S, Treanor JJ, Lew JF. Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus. J Clin Microbiol 1997;35:1909--14.
  32. Hale AD, Crawford SE, Ciarlet M, et al. Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin Diagn Lab Immunol 1999;6:142--5.
  33. Leite JP, Ando T, Noel JS, et al. Characterization of Toronto virus capsid protein expressed in baculovirus. Arch Virol 1996;141:865--75.
  34. Deneen VC, Hunt JM, Paule CR, et al. Impact of foodborne calicivirus disease: the Minnesota experience. J Infect Dis 2000;181(suppl 2):S281--3.
  35. Fankhauser RL, Noel JS, Monroe SS, Ando T, Glass RI. Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States. J Infect Dis 1998;178:1571--8.
  36. Vinje J, Altena SA, Koopmans MP. Incidence and genetic variability of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. J Infect Dis 1997;176:1374--8.
  37. Vinje J, Koopmans MP. Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. J Infect Dis 1996;174:610--5.
  38. Maguire AJ, Green J, Brown DW, Desselberger U, Gray JJ. Molecular epidemiology of outbreaks of gastroenteritis associated with small round-structured viruses in East Anglia, United Kingdom, during the 1996--1997 season. J Clin Microbiol 1999;37:81--9.
  39. Inouye S, Yamashita K, Yamadera S, Yoshikawa M, Kato N, Okabe N. Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents. J Infect Dis 2000;181(suppl 2):S270--4.
  40. Hedlund KO, Rubilar-Abreu E, Svensson L. Epidemiology of calicivirus infections in Sweden, 1994--1998. J Infect Dis 2000;181(suppl 2):S275--80.
  41. Nakata S, Honma S, Numata KK, et al. Members of the family Caliciviridae\t (Norwalk virus and Sapporo virus) are the most prevalent cause of gastroenteritis outbreaks among infants in Japan. J Infect Dis 2000;181:2029--32.
  42. Greening GE, Miriams M, Berke T. Molecular epidemiology of "Norwalk-like viruses" associated with gastroenteritis outbreaks in New Zealand. J Med Virol 2001;64:58--66.
  43. Dowell SF, Groves C, Kirkland KB, et al. Multistate outbreak of oyster-associated gastroenteritis: implications for interstate tracing of contaminated shellfish. J Infect Dis 1995;171:1497--503.
  44. Kohn MA, Farley TA, Ando T, et al. Outbreak of Norwalk virus gastroenteritis associated with eating raw oysters: implications for maintaining safe oyster beds. JAMA 1995;273:466--71.
  45. Beller M, Ellis A, Lee SH, et al. Outbreak of viral gastroenteritis due to a contaminated well. JAMA 1997;278:563--8.
  46. Daniels NA, Bergmire-Sweat DA, Schwab KJ, et al. Foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis 2000;181:1467--70.
  47. Kilgore PE, Belay ED, Hamlin DM, et al. University outbreak of gastroenteritis due to a small round-structured virus: application of molecular diagnostics to identify the etiologic agent and patterns of transmission. J Infect Dis 1996;173:787--93.
  48. Parashar UD, Dow L, Fankhauser RL, et al. Outbreak of viral gastroenteritis associated with consumption of sandwiches: implications for the control of transmission by food handlers. Epidemiol Infect 1998;121:615--21.
  49. Ponka A, Maunula L, von Bonsdorff CH, Lyytikainene O. Outbreak of calicivirus gastroenteritis associated with eating frozen raspberries. Epidemiol Infect 1999;123:469--74.
  50. Green KY, Ando T, Balayan MS, et al. Taxonomy of the caliciviruses. J Infect Dis 2000;181(suppl 2):S322--30.
  51. Ando T, Noel JS, Fankhauser RL. Genetic classification of "Norwalk-like viruses." J Infect Dis 2000;181(suppl 2):S336--48.
  52. Mounts AW, Holman RC, Clarke MJ, Bresee JS, Glass RI. Trends in hospitalizations associated with gastroenteritis among adults in the United States, 1979--1995. Epidemiol Infect 1999;123:1--8.
  53. de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Bartelds AI, van Duynhoven YT. Gastroenteritis in sentinel general practices, the Netherlands. Emerg Infect Dis 2001;7:82--91.
  54. Tompkins DS, Hudson MJ, Smith HR, et al. Study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health 1999;2:108--13.
  55. Koopmans M, Vinje J, de Wit M, Leenen I, van der Poel W, van Duynhoven Y. Molecular epidemiology of human enteric caliciviruses in the Netherlands. J Infect Dis 2000;181(suppl 2):S262--9.
  56. Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis 1998;4:562--70.
  57. Kogawa K, Nakata S, Ukae S, et al. Dot blot hybridization with a cDNA probe derived from the human calicivirus Sapporo 1982 strain. Arch Virol 1996;141:1949--59.
  58. Numata K, Nakata S, Jiang X, Estes MK, Chiba S. Epidemiological study of Norwalk virus infections in Japan and Southeast Asia by enzyme-linked immunosorbent assays with Norwalk virus capsid protein produced by the baculovirus expression system. J Clin Microbiol 1994;32:121--6.
  59. Wolfaardt M, Taylor MB, Booysen HF, Engelbrecht L, Grabow WO, Jiang X. Incidence of human calicivirus and rotavirus infection in patients with gastroenteritis in South Africa. J Med Virol 1997;51:290--6.
  60. O'Ryan ML, Mamani N, Gaggero A, et al. Human caliciviruses are a significant pathogen of acute sporadic diarrhea in children of Santiago, Chile. J Infect Dis 2000;182:1519--22.
  61. Bon F, Fascia P, Dauvergne M, et al. Prevalence of group A rotavirus, human calicivirus, astrovirus, and adenovirus type 40 and 41 infections among children with acute gastroenteritis in Dijon, France. J Clin Microbiol 1999;37:3055--8.
  62. Espinoza F, Paniagua M, Hallander H, Hedlund KO, Svensson L. Prevalence and characteristics of severe rotavirus infections in Nicaraguan children. Ann Trop Paediatr 1997;17:25--32.
  63. Qiao H, Nilsson M, Abreu ER, et al. Viral diarrhea in children in Beijing, China. J Med Virol 1999;57:390--6.
  64. Cubitt WD, Jiang X. Study on occurrence of human calicivirus (Mexico strain) as cause of sporadic cases and outbreaks of calicivirusassociated diarrhoea in the United Kingdom, 1983--1995. J Med Virol 1996;48:273--7.
  65. Pang XL, Joensuu J, Vesikari T. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 1999;18:420--6.
  66. Adler JL, Zickl R. Winter vomiting disease. J Infect Dis 1969;119:668--73.
  67. Caul EO. Small round structured viruses: airborne transmission and hospital control. Lancet 1994;343:1240--2.
  68. Chadwick PR, McCann R. Transmission of a small round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect 1994;26:251--9.
  69. Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000;124:481--7.
  70. Cheesbrough JS, Green J, Gallimore CI, Wright PA, Brown DW. Widespread environmental contamination with Norwalk-like viruses (NLV) detected in a prolonged hotel outbreak of gastroenteritis. Epidemiol Infect 2000;125:93--8.
  71. Green J, Wright PA, Gallimore CI, Mitchell O, Morgan-Capner P, Brown DW. Role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect 1998;39:39--45.
  72. Becker KM, Moe CL, Southwick KL, MacCormack JN. Transmission of Norwalk Virus during a Football Game. N Engl J Med 2000;343:1223--7.
  73. Thornhill TS, Kalica AR, Wyatt RG, Kapikian AZ, Chanock RM. Pattern of shedding of the Norwalk particles in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis 1975;132:28--34.
  74. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994;170:34--43.
  75. Okhuysen PC, Jiang Xi, Ye L, Johnson PC, Estes MK. Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis 1995;171:566--9.
  76. Iversen AM, Gill M, Bartlett CL, Cubitt WD, McSwiggan DA. Two outbreaks of foodborne gastroenteritis caused by a small round structured virus: evidence of prolonged infectivity in a food handler. Lancet 1987;2:556--8.
  77. Reid JA, Caul EO, White DG, Palmer SR. Role of infected food handler in hotel outbreak of Norwalk-like viral gastroenteritis: implications for control. Lancet 1988;2:321--3.
  78. White KE, Osterholm MT, Mariotti JA, et al. Foodborne outbreak of Norwalk virus gastroenteritis: evidence for post-recovery transmission. Am J Epidemiol 1986;124:120--6.
  79. Patterson T, Hutchings P, Palmer S. Outbreak of SRSV gastroenteritis at an international conference traced to food handled by a post-symptomatic caterer. Epidemiol Infect 1993;111:157--62.
  80. Lo SV, Connolly AM, Palmer SR, Wright D, Thomas PD, Joynson D. Role of the pre-symptomatic food handler in a common source outbreak of food-borne SRSV gastroenteritis in a group of hospitals. Epidemiol Infect 1994;113:513--21.
  81. Kapikian AZ, Estes MK, Chanock RM. Norwalk group of viruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. Philadelphia, PA: Lippincott-Raven, 1996;783--810.
  82. Keswick BH, Satterwhite TK, Johnson PC, et al. Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol 1985;50:261--4.
  83. McDonnell S, Kirkland KB, Hlady WG, et al. Failure of cooking to prevent shellfish-associated viral gastroenteritis. Arch Intern Med 1997;157:111--6.
  84. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977;297:86--9.
  85. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 1990;161:18--21.
  86. Marx A, Shay DK, Noel JS, et al. Outbreak of acute gastroenteritis in a geriatric long-term-care facility: combined application of epidemiological and molecular diagnostic methods. Infect Cont Hosp Epidemiol 1999;20:306--11.
  87. Jiang X, Turf E, Hu J, et al. Outbreaks of gastroenteritis in elderly nursing homes and retirement facilities associated with human caliciviruses. J Med Virol 1996;50:335--41.
  88. McAnulty JM, Rubin GL, Carvan CT, Huntley EJ, Grohmann G, Hunter R. Outbreak of Norwalk-like gastroenteritis associated with contaminated drinking water at a caravan park. Aust J Public Health 1993;17:36--41.
  89. Kukkula M, Maunula L, Silvennoinen E, von Bonsdorff CH. Outbreak of viral gastroenteritis due to drinking water contaminated by Norwalk-like viruses. J Infect Dis 1999;180:1771--6.
  90. Brugha R, Vipond IB, Evans MR, et al. Community outbreak of food-borne small round-structured virus gastroenteritis caused by a contaminated water supply. Epidemiol Infect 1999;122:145--54.
  91. Khan AS, Moe CL, Glass RI, et al. Norwalk virus-associated gastroenteritis traced to ice consumption aboard a cruise ship in Hawaii: comparison and application of molecular method-based assays. J Clin Microbiol 1994;32:318--22.
  92. Koo D, Maloney K, Tauxe R. Epidemiology of diarrheal disease outbreaks on cruise ships, 1986 through 1993. JAMA 1996;275:545--7.
  93. McCarthy M, Estes MK, Hyams KC. Norwalk-like virus infection in military forces: epidemic potential, sporadic disease, and the future direction of prevention and control efforts. J Infect Dis 2000;181(suppl 2):S387--91.
  94. Ho MS, Glass RI, Monroe SS. Viral gastroenteritis aboard a cruise ship. Lancet 1989;2:961--5.
  95. Shieh Y, Monroe SS, Fankhauser RL, Langlois GW, Burkhardt W 3rd, Baric RS. Detection of Norwalk-like virus in shellfish implicated in illness. J Infect Dis 2000;181(suppl 2):S360--6.
  96. Burkhardt W 3rd, Calci KR. Selective accumulation may account for shellfish-associated viral illness. Appl Environ Microbiol 2000;66:1375--8.
  97. LeBaron CW, Furutan NP, Lew JF, et al. Viral agents of gastroenteritis: public health importance and outbreak management. MMWR 1990;39(RR-5):1--24.
  98. Atmar RL, Estes MK. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev 2001;14:15--37.

* Taxonomy nomenclature source: van Regenmortel MHV, Fauquet CM, Bishop DHL, et al., eds. Virus taxonomy: seventh report of the International Committee on Taxonomy of Viruses. New York, NY: Academic Press, Inc., 1999.

**A summary table with instructions for collecting clinical specimens during outbreaks to test for bacteria, viruses, and parasites is available at <http://www.cdc.gov/ncidod/dbmd/outbreak/guide_sc.htm> (accessed May 1, 2001).


Table 1

Table 1
Return to top.
Figure 1

Figure 1
Return to top.
Table 2

Table 1
Return to top.
Figure 2

Figure 2
Return to top.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #